Trial
NCT00303433
Namenda to Prevent Post-Operative Delirium
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Rochester
Collaborators
Forest Laboratories
Condition
Delirium
Intervention
Namenda
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-06-03